Overview

Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?

Status:
Completed
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
Parathyroid (PTH) hormone has been shown to enhance fracture healing in animal studies. There are so far only three published papers concerning humans. Postero-lateral fusions have shown a healing rate of less than 50% after bone. The purpose of this study is to determine if PTH 1-34 (teriparatide) improves the healing rate and the clinical course after spinal stenosis surgery.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Linkoeping
Collaborator:
Medical Research Council of Southeast Sweden
Treatments:
Teriparatide